South Korean government study also shows that NPEs continue to target foreign defendants in places like Marshall, Texas (pictured) post TC Heartland
Vivo is firmly in the same smartphone sales tier as companies like Oppo and Xiaomi, but it has pursued a low-key IP strategy very different to that of its chief rivals
SiOnyx, which is owned by the investment giant, and co-plaintiff Harvard accuses Japanese optical devices manufacturer of patent infringement
The auto company is the biggest shareholder in the parts giant, a growing IP power which is ramping up its ability to make electric vehicle parts
Lack of IP funds and staff at Kyoto University may have left immunotherapy pioneer Tasuku Honjo with a poor deal in agreement with Ono Pharmaceutical.
As this disruptive technology attracts increasing interest, key issuing authorities are developing different ways of handling applications that read on it
Recent assignments showcase different ways Huawei reaps value from patent deals: one sealing its settlement with Samsung, another arming America’s most prolific NPE
“We’ve used them as a litigation firm in the past, they know our portfolio really well and we wanted to take the opportunity to leverage that expertise more broadly to focus it on co-developing licensing programmes along with our own team,” says Invention Investment Fund head Mathen Ganesan
In an interview with IAM, firm president Joe Siino (pictured, far right) also confirms expansion of operations in Hong Kong, with former Technicolor licensing head Deirdre Leane soon to join the team
In run-up to possible $100 billion IPO, Uber prospectus raises possibility of paying for a licence to one-time litigation rival’s technology
Senior exec at ride-sharing leader reveals how his role has changed, how he has handled the transition from in-house to private practice and back and how he thinks IP strategy is set to evolve.
The high invalidation rate for life science patents in China has created a headache for drug companies and a money-making opportunity for enterprising individuals
How to tailor your filing strategy in a post-AIA world with fast track and deferred examination
Firms welcomed tougher measures against infringers at IPBC Korea 2019 last week, but there are concerns about a recent initiative to attract more foreign litigants through the use of English-language hearings
Everything you need to know about the major news stories in the life sciences sector that broke last month